|Munck Wilson Mandala Attorney Michael Wilson quoted in Dallas Business Journal article |
Galderma takes on Watson, Actavis in patent suit
|August 1, 2012 11:42 pm|
The Dallas Business Journal:
Galderma is seeking to stop a pair of pharmaceutical makers from producing and selling generic versions of a drug for severe acne, according to two related lawsuits filed in Dallas federal court and a news release.
Galderma SA of Switzerland and its Fort Worth-based U.S. arm, Galderma Laboratories LP, also are seeking to delay approval by the federal Food and Drug Administration of the generic sale of Epiduo Gel until a handful of patents expire, the lawsuits show.
© 2012 American City Business Journals.
Send this page to a friend